Page last updated: 2024-08-26

imipenem, anhydrous and Infections, Klebsiella

imipenem, anhydrous has been researched along with Infections, Klebsiella in 179 studies

Research

Studies (179)

TimeframeStudies, this research(%)All Research%
pre-19904 (2.23)18.7374
1990's14 (7.82)18.2507
2000's48 (26.82)29.6817
2010's85 (47.49)24.3611
2020's28 (15.64)2.80

Authors

AuthorsStudies
Cornaglia, G; Koncan, R; Mazzariol, A; Roelofsen, E; Voss, A1
Carmeli, Y; Chmelnitsky, I; Leavitt, A; Navon-Venezia, S; Schwaber, MJ1
Cuzon, G; Demachy, MC; Naas, T; Nordmann, P1
Cuzon, G; Lartigue, MF; Naas, T; Nordmann, P; Quinn, JP; Villegas, MV1
Bethel, CR; Bonomo, RA; Carias, LL; Endimiani, A; Fox, WR; Hall, GS; Hujer, AM; Hujer, KM; Hutton, RA; Jacobs, MR; Jenkins, SG; Paterson, DL; Perez, F; Rice, LB; Tenover, FC1
Apisarnthanarak, A; Kiratisin, P; Laesripa, C; Saifon, P1
Badur, S; Cagatay, AA; Carrër, A; Eraksoy, H; Nordmann, P; Poirel, L1
Bogaerts, P; Cuzon, G; Glupczynski, Y; Huang, TD; Naas, T; Nordmann, P1
Arpin, C; Bezian, MC; Coulange, L; Demarthe, F; Dubois, V; Minarini, LA; Nordmann, P; Poirel, L; Quentin, C1
Della-Latta, P; Dib-Hajj, F; Dougherty, BA; Gootz, TD; He, W; Huard, RC; Lescoe, MK1
Baraniak, A; Fiett, J; Filczak, K; Gniadkowski, M; Herda, M; Hryniewicz, W; Izdebski, R; Kern-Zdanowicz, I; Łopaciuk, U1
Chung, DR; Ko, KS; Peck, KR; Son, JS; Song, JH; Suh, JY1
Cho, HS; Giske, CG; Lee, K; Sundman, K; Toleman, MA; Walsh, TR; Yong, D1
Albertí, S; Bengoechea, JA; Doménech-Sánchez, A; Llobet, E; Martínez-Martínez, L; Padilla, E1
Choi, JY; Ko, KS; Lee, MY; Park, YK; Peck, KR; Rhee, JY; Shin, JY; Song, JH1
Carmeli, Y; Chmelnitsky, I; Goren, MG; Leavitt, A; Navon-Venezia, S; Ofek, I1
Badal, RE; Baquero, F; Bouchillon, SK; Cantón, R; Hawser, SP; Hoban, DJ1
Bonomo, RA; Endimiani, A; Hujer, AM; Hujer, KM; Pulse, ME; Weiss, WJ1
Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G1
Campagne, JM; Gerber, C; Gualtieri, M; Marcia de Figueiredo, R; Midrier, C; Pantel, L; Racine, E; Sarciaux, M; Serri, M; Villain-Guillot, P1
Chai, Z; Liu, H; Liu, J; Lu, J; Min, Z; Muhammad, M; Yang, Y; Zhang, L1
Haider Naqvi, SZ; Malik, A; Muddassir, M; Mumtaz, K; Munir, S; Raza, A; Shoaib Ahmed, S; Waqas, K1
Chen, Y; Luo, Q; Qiu, Y; Shen, P; Xiao, Y; Xu, H; Yu, W1
Li, S; Liu, W; Mo, Q; Shao, M; Sun, L; Ying, N; Zhu, L1
Ambretti, S; Gaibani, P; Lazzarotto, T; Lombardo, D1
Lin, Z; Liu, S; Yu, J; Zhu, M1
Amadesi, S; Ambretti, S; Bartoletti, M; Bovo, F; Bussini, L; Gaibani, P; Lazzarotto, T; Viale, P1
Chen, H; Li, N; Liang, W; Wang, F; Wang, L1
Akrami, S; Alkhudhairy, MK; Benyagoub, E; Raouf, FEA; Saki, M1
Al Atbee, MYN; Jalil, MB1
Cai, H; Guo, Q; He, T; Li, D; Wang, D; Wang, M; Xu, X; Yuan, Y1
Findlay, J; Nordmann, P; Poirel, L; Rens, C1
Bandić-Pavlović, D; Barišić, I; Beader, N; Bedenić, B; Frančula-Zaninović, S; Krilanović, M; Pešorda, L; Schoenthaler, S; Veir, Z1
Fang, SB; Fujisawa, M; Kado, M; Maeda, K; Onishi, R; Osawa, K; Shigemura, K; Tanimoto, H; Yang, YM1
Deng, Y; Huang, W; Li, J; Qiao, F; Zhang, W; Zhu, S; Zong, Z1
Shamsuzzaman, SM; Sonia, SJ; Uddin, KH1
Lukovic, B; Petrovic, I; Zornic, S1
Akrami, S; Al-Dahmoshi, HOM; Al-Khafaji, NSK; Bannazadeh Baghi, H; Jafari-Sales, A; Judi, HK; Nasiri, R; Sadeghi Deylamdeh, Z; Saki, M; Shariat, A1
Goudarzi, G; Shakib, P1
Esmail, MAM; Khairy, RMM; Mahmoud, MS; Shady, RR1
Al-Zaban, MI; AlHarbi, MA; Azim, NSA; Nofal, MY; Somily, AM1
Antinori, E; Bertoncelli, A; Mazzariol, A; Unali, I1
Adeleye, AI; Ajayi, A; Akinpelu, S; Smith, SI1
Cao, J; Dhanasekaran, V; Fang, R; Li, J; Lithgow, T; Liu, H; Perlaza-Jiménez, L; Tian, X; Wang, C; Wang, Q; Zhao, Y; Zheng, X; Zhou, T1
Hirabayashi, A; Kajihara, T; Shibayama, K; Sugai, M; Yahara, K1
Bian, W; Chen, W; Gu, X; Liu, Y; Qin, Y; Wang, S; Zhao, G1
Borghi, M; Devereux, M; Ferreira Ventura, R; FerreiraNunes, AP; McCann, M; Pinto Schuenck, R; Souza Dos Santos, AL; Vianez Peregrino, I1
Blasco, L; Bleriot, I; Bou, G; Domingo-Calap, P; Fernández-Cuenca, F; Fernández-García, L; González-Bardanca, M; López, M; Martínez-Martínez, L; Oteo, J; Pacios, O; Pascual, Á; Tomás, M1
Cai, J; Cui, W; Huang, J; Qian, Z; Song, F; Zhang, G; Zhang, K; Zheng, C; Zhou, F; Zhou, H1
Astashkin, EI; Ershova, ON; Fursova, NK; Kartsev, NN; Lev, AI; Platonov, ME; Shaikhutdinova, RZ; Svetoch, EA; Volozhantsev, NV1
Aires, CAM; Albano, RM; Asensi, MD; Carvalho-Assef, APD; da Conceição-Neto, OC; Dias, CF; Montezzi, LF; Picão, RC; Tavares E Oliveira, TR1
Kramer, J; Proschak, A; Proschak, E; Wichelhaus, TA1
Badal, R; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S1
Arlet, G; Boutiba-Ben Boubaker, I; Ferjani, S; Fernandez Martinez, M; Genel, N; Hammami, S; Hamzaoui, Z; Harbaoui, S; Maamar, E; Martinez-Martinez, L; Ocampo-Sosa, A; Saidani, M; Slim, A1
Cha, MK; Chung, DR; Kang, CI; Kim, SH; Lee, NY; Peck, KR; Song, JH1
Bogaerts, P; Bonnin, RA; Dabos, L; Glupczynski, Y; Huang, DT; Iorga, BI; Naas, T; Sacré, P; Zavala, A1
Atrkar Roushan, Z; Ghaffarian, F; Hedayati, M; Mojtahedi, A; Sedigh Ebrahim-Saraie, H1
Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A1
Abdul Jabar, K; Chai, LC; Chong, CW; Clarke, SC; Low, YM; Md Yusof, MY; Ponnampalavanar, S; Teh, CSJ; Yap, IKS1
Bao, C; Chin, W; Ding, B; Fan, W; Gao, S; Hedrick, JL; Hsu, LY; Lee, A; Leong, J; Lou, W; Pu, Q; Tan, JPK; Wu, M; Xu, L; Yang, C; Yang, YY; Zhong, G1
Al-Bustan, SA; Alkhudhairy, MK; Alshadeedi, SMJ; Ghasemian, A; Mahmood, SS1
Jiang, C; Liu, L; Liu, N; Xie, N; Xu, Y; Zhang, G1
Bou Casals, J; Daikos, GL; Kotsakis, SD; Miriagou, V; Tzelepi, E; Tzouvelekis, LS1
Harino, T; Kashiyama, S; Kayama, S; Kuwahara, R; Ohge, H; Onodera, M; Shigemoto, N; Sugai, M; Yokozaki, M1
Arslan, H; Azap, OK; Çolakoğlu, Ş; Evren, E1
Damjanova, I; Kádár, B; Kocsis, B; Kristóf, K; Nagy, K; Szabó, D; Szász, M; Tóth, Á1
Imon, K; Ishino, T; Kayama, S; Kuwahara, R; Ohge, H; Onodera, M; Shigemoto, N; Sugai, M; Yokozaki, M1
Biçmen, M; Gülay, Z; Sarı, AN1
Abercrombie, JJ; Chen, P; Leung, KP; Mustoe, TA; Seth, AK1
Belghiti, J; Bert, F; Dondero, F; Durand, F; Larroque, B; Moreau, R; Nicolas-Chanoine, MH; Paugam-Burtz, C1
Bonomo, RA; Cline, M; Cober, E; Conlan, S; Evans, S; Fowler, VG; Fox, J; Hall, GS; Hanrahan, J; Jacobs, MR; Kalayjian, RC; Kaye, KS; Mason, P; Perez, F; Richter, SS; Rudin, SD; Salata, RA; Segre, JA; van Duin, D; Webber, R; Ziegler, J1
Aissa, N; Bertrand, X; Blanc, V; Cavalié, L; de Champs, C; Eloy, C; Guyeux, C; Hocquet, D; Lavigne, JP; Liapis, E; Nicolas-Chanoine, MH; Pantel, A; Robert, J; van der Mee-Marquet, N1
Gu, B; Mei, Y; Wen, Y; Xia, W; Zhang, X1
Kim, KH; Lee, JY1
Chen, Z; Li, L; Sun, Z; Tian, L; Wang, Y; Yan, S; Zhang, B; Zhu, X1
Mangin, E; Mavridou, E; Melchers, RJ; Motyl, MR; Mouton, JW; van Mil, AC1
Ahn, S; Han, WD; Kim, ES; Kim, HB; Kim, NH; Kim, TS; Park, KU; Seo, HK; Shin, MJ; Song, KH; Yoo, JS1
Cao, XW; Deng, Q; Liu, Y; Wan, LG; Wei, DD; Xu, QF; Yu, Y1
Cuesta-Bernal, J; El-Delik, J; Frank, D; Göttig, S; Klingler, FM; Koenigs, A; Müller, HF; Pogoryelov, D; Pos, KM; Proschak, E; Sjuts, H; Wichelhaus, TA1
Abdelhaleim, M; AbdulRahman, E; Ghaith, D; Wassef, M1
Chuang, YC; Ku, YH; Lee, MF; Tang, HJ; Yu, WL1
Gentry, CA; Williams, RJ1
Chan, YJ; Chuang, C; Chuang, YC; Fung, CP; Huang, CT; Lin, YT; Siu, LK; Su, CF; Wang, LS1
De Luca, F; Docquier, JD; Hrabák, J; Papagiannitsis, CC; Pollini, S; Rossolini, GM1
Chongtrakool, P; Diraphat, P; Malathum, K; Pornsinchai, P; Siripanichgon, K1
Barrios, H; Carrillo-Casas, EM; Garza-Ramos, U; Hernández-Castro, R; Moncada-Barron, D; Moreno-Dominguez, S; Reyna-Flores, F; Sanchez-León, MC; Sanchez-Perez, A; Silva-Sanchez, J1
Hung, YP; Ko, WC; Lee, JC; Li, CW; Li, MC; Lin, HJ; Liu, HC; Wu, YH1
Calfee, DP; Eiras, DP; Furuya, EY; Gomez-Simmonds, A; Jenkins, SG; Kubin, CJ; Loo, A; Nelson, B; Satlin, MJ; Whittier, S1
Damjanova, I; Fenyvesi, H; Jakab, G; Jánvári, L; Kovács, K; Melegh, S; Mestyán, G; Nyul, A; Szabó, H; Tóth, Á1
Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M1
Ciszek, M; Dobrzaniecka, K; Grochowiecki, T; Grygiel, K; Młynarczyk, G; Pączek, L; Sańko-Resmer, J; Wilkowski, P; Łabuś, A1
Chan, YJ; Chuang, C; Chuang, YC; Fung, CP; Lin, YT; Siu, LK; Su, CF; Wang, FD; Wu, PF1
Battikh, H; Dekhili, A; Fendri, C; Harchay, C; Kechrid, F; Khazar, K; Masmoudi, A; Zribi, M1
Ahmad, I; Akhtar, T; Ambreen, A; Gandapor, AJ; Khan, A; Khan, AM; Ullah, O1
Ajao, AO; Albrecht, JS; Furuno, JP; Harris, AD; Johnson, JK; Pineles, LL; Robinson, GL; Thom, KA; Zhao, L1
Douzinas, EE; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Piperaki, E; Tzouvelekis, LS1
Guo, Y; Yang, D; Zhang, Z1
Espinal-Witter, R; Larone, DH; Morgan, DJ; Weisenberg, SA1
Ahmad, S; Al-Juaid, NF; Alenzi, FQ; Bakheet, Oel-S; Mattar, EH1
Choe, KW; Jeon, JH; Kim, HB; Kim, NJ; Lee, HS; Oh, MD; Park, SW; Park, WB; Song, KH1
Ahmadi, S; Bazzaz, BS; Farshadzadeh, Z; Mohamadpoor, AH; Naderinasab, M; Yousefi, F1
Balan, G; Lim, KT; Md Yasin, R; Thong, KL; Yeo, CC1
Faccone, D; Galas, M; López, Y; Maggi, G; Marcano, D; Pasterán, F; Payares, D; Rapoport, M; Salgado, N; Sánchez, D; Spadola, E; Ugarte, C1
Cuzon, G; Guibert, M; Naas, T; Nordmann, P1
Bragatti, JA; Cabral, L; Finkelsztejn, A; Schuh, AF; Silva, AV1
Daikos, GL; Douzinas, E; Legakis, NJ; Miriagou, V; Tsakiri, M; Tzelepi, E; Tzouvelekis, LS; Zioga, A1
Chong, Y; Kim, JJ; Kim, S; Koh, E; Lee, CH; Lee, J; Lee, K; Lee, MA; Roh, KH; Yong, D1
Aygencel, G; Dizbay, M1
Barsaoui, S; Ben Jaballah, N; Bousnina, S; Bouziri, A; Hajji, N; Hariga, D; Kechrid, A; Sammoud, A; Smaoui, H1
Abbanat, D; Barron, A; Bunting, RA; Fernandez, J; Flamm, RK; Hall, L; Hilliard, JJ; Lynch, AS; Melton, JL; Ward, CK1
Arlet, G; Boutelier, C; Carbonne, A; Castaing, D; Decre, D; Dussaix, E; Gastiaburu, N; Guerin, C; Jarlier, V; Kassis-Chikhani, N; Lavigne-Kriaa, A; Neuville, S; Saliba, F; Samuel, D; Sengelin, C1
Cai, J; Liu, J; Wu, D1
Chiang, T; Colon-Urban, R; Eng, RH; Gomez, E; Huang, DB; Mariano, N; Urban, C1
Ersoy, Y; Görgeç, S; Kuzucu, C; Yetkin, F1
Basu, S; Das, P; Roy, S; Singh, AK; Viswanathan, R1
Hsueh, PR; Huang, WH; Ko, WC; Lee, NY; Tsui, KC1
Raghunathan, A; Samuel, L; Tibbetts, RJ1
Badal, RE; Bouchillon, SK; Hackel, M; Hawser, SP; Hoban, DJ; Lascols, C; Livermore, DM; Woodford, N1
Hisatsune, J; Kato, F; Kayama, S; Kuwahara, R; Ohge, H; Onodera, M; Shigemoto, N; Shimizu, W; Sugai, M; Yokozaki, M1
Hisatsune, J; Kato, F; Kayama, S; Kuwahara, R; Ohge, H; Onodera, M; Shigemoto, N; Sugai, M; Yokozaki, M1
Maherault, AC; Nordmann, P; Pangon, B; Therby, A1
Cao, W; Chen, Z; Li, L; Liu, C; Sun, Z; Tian, L; Wang, B; Wang, F; Wang, Y; Zhang, B; Zhu, X1
Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L1
Bhagunde, P; Chang, KT; Hirsch, EB; Ledesma, KR; Nikolaou, M; Tam, VH1
Hsueh, PR; Huang, WH; Ko, WC; Lee, CC; Lee, NY; Tsui, KC1
Anderson, DJ; Bennett, KM; Dotson, TL; Sarraf-Yazdi, S; Sharpe, M; Vaslef, SN1
Aleo, A; Bonura, C; Brunelli, T; Degl'Innocenti, R; Fasciana, T; Mammina, C; Nastasi, A; Pesavento, G1
Bansal, N; Chander, J; Gupta, V; Singla, N1
Boyle, F; Boyle, L; Brisse, S; Burns, K; Condon, I; Cormican, M; Delannoy-Vieillard, AS; Finnegan, C; Humphreys, H; Khan, A; Monahan, R; Morris, C; Morris, D; Morris-Downes, M; O'Connell, N; O'Gorman, A; Powell, J; Power, L; Turton, J; Woodford, N1
Aiello, E; D'Ancona, F; Dematte, L; Goglio, A; Meledandri, M; Pantosti, A; Raglio, A; Rossolini, GM; Serra, R; Sisto, A1
Hsieh, MH; Lu, PL; Ma, L; Siu, LK1
Chen, H; Li, Z; Shen, W; Yuehua, X; Zhou, H; Zhou, L1
Colakoğlu, S; Durmaz, S; Ekincioğlu, P; Perçin, D1
Chen, P; Cheng, WC; Xiang, XD; Zan, JN1
Cimiotti, J; Della-Latta, P; Gupta, A; Larson, E; Loughrey, M; Rubenstein, D; Saiman, L; Stone, PW1
Amicosante, G; Colì, A; Endimiani, A; Lombardi, G; Luzzaro, F; Perilli, M; Tamborini, A; Toniolo, A1
Bonomo, RA; Casellas, JM; Goossens, H; Klugman, KP; Ko, WC; McCormack, JG; Mohapatra, S; Mulazimoglu, L; Paterson, DL; Rice, LB; Trenholme, G; Von Gottberg, A; Wagener, MM; Yu, VL1
Cho, YK; Kim, SY; Lee, ES; Lee, SO; Park, SY; Seo, YH1
Cassettari, VC; Gales, AC; Lincopan, N; Mamizuka, EM; McCulloch, JA; Reinert, C1
Bernabéu-Wittel, M; de Cueto, M; del Carmen Conejo, M; García, I; Jiménez-Mejías, ME; Martínez-Martínez, L; Pachón, J; Pachón-Ibáñez, ME; Pascual, A; Pichardo, C1
Conejo, C; Ibáñez-Martínez, J; Martínez-Martínez, L; Pachón, J; Pachón-Ibañez, ME; Pascual, A; Pichardo, C; Rodríguez-Martínez, JM1
Arlet, G; Bidet, P; Bingen, E; Brahimi, N; Burghoffer, B; El-Ghoneimi, A; Gautier, V; Mariani-Kurkdjian, P1
Bratu, S; Landman, D; Quale, J; Salvani, JK1
Chong, Y; Ha, GY; Jeong, SH; Lee, K; Lim, HS; Park, KH; Shin, JH; Yong, D1
Albertí, S; Alonso, D; Borrell, N; Doménech-Sánchez, A; Gomez, C; Padilla, E; Pérez, JL1
Kim, HS; Kim, SY; Lee, K; Park, YJ; Park, YS; Yoo, JY; Yoon, JB; Yu, JK1
Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M1
Avlami, A; Daikos, GL; Gargalianos, P; Karabinis, A; Kosmidis, C; Malamou-Lada, H; Paramythiotou, E; Petropoulou, D; Syriopoulou, VP; Tzanetou, K1
Anderlik, P; Máthé, A; Nagy, K; Rozgonyi, F; Szabó, D1
Bae, IK; Bae, SJ; Jeong, SH; Lee, JH; Lee, SH1
Gin, GG; Karunakaran, R; Muniandy, S; Palasubramaniam, S; Parasakthi, N1
Carrero, HA; Erwin, DP; Ewell, AJ; Mody, RM; Moran, KA; Selby, EB; Summers, AM1
Donskey, CJ; Pultz, MJ1
Chen, YS; Chiu, CJ; Chu, C; Lee, CH; Liu, JW; Su, LH1
Guglielmo, BJ; Yang, K1
Ivanov, DV1
Etoh, T; Hirose, M; Ishibashi, H; Muro, H; Ohta, S; Shirasu, T; Suzuki, K; Tanio, N1
Conejo, MC; Hernández, JR; Pascual, A1
Alford, RH; Brown, TH1
Ehrhardt, AF; Sanders, CC; Thomson, KS; Trujillano-Martin, I; Watanakunakorn, C1
Grayson, ML; Stuart, RL; Turnidge, J1
Goto, S; Matsunaga, T; Nagashima, M; Ogawa, M; Shimohira, H; Yoshida, T1
Bradford, PA; Bush, K; Mariano, N; Projan, SJ; Rahal, JJ; Urban, C1
Confino-Cohen, R; Goldberg, A; Lang, R1
Amyes, SG; Dorai-John, T; Forbes, KJ; Gould, IM; MacKenzie, FM1
Adhikari, M; Pillay, DG; Pillay, T; Sturm, AW1
Burns, JM; Dominick, D; Freeman, K; Horn, D; Lim, M; Mariano, N; Marks, S; Maurer, J; Rahal, JJ; Segal-Maurer, S; Urban, C1
Lawrence, C; Nauciel, C; Ronco, E1
Nagy, E; Pragai, Z1
Ahmad, M; Bradford, PA; Bush, K; Calcagni, E; Mariano, N; Projan, SJ; Rahal, JJ; Urban, C1
Anderlik, P; Filetóth, Z; Máthé, A; Rókusz, L; Rozgonyi, F; Szabó, D1
Hostacká, A1
Díez García, F; Gallego Rojo, FJ; Salas Coronas, J; Sánchez Sánchez, JC1
Goodwin, CS; Nsanze, H; Topley, J; Varady, E; Worsley, BW1
Aubert, G; Boylot, D; Brunon, J; Dorche, G; Duthel, R; Jacquemond, G; Pozzetto, B1
Amano, H; Kawazu, H; Nishiwaki, K; Saito, H; Saka, H; Sakai, S; Senda, Y; Shimokata, K; Torii, Y; Yamamoto, M1
Calame, W; Craig, WA; Ebert, S; Fantin, B; Leggett, JE; Mattie, H; Totsuka, K; Vogelman, B1
Casali, W; Cogo, R; Falchi, M; Fraschini, F; Gattei, G; Scaglione, F1
Chadwick, EG; Shulman, ST; Yogev, R1

Reviews

1 review(s) available for imipenem, anhydrous and Infections, Klebsiella

ArticleYear
Diagnosis and treatment of extended-spectrum and AmpC beta-lactamase-producing organisms.
    The Annals of pharmacotherapy, 2007, Volume: 41, Issue:9

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftriaxone; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins

2007

Trials

2 trial(s) available for imipenem, anhydrous and Infections, Klebsiella

ArticleYear
Bacteremia due to Klebsiella pneumoniae isolates producing the TEM-52 extended-spectrum beta-lactamase: treatment outcome of patients receiving imipenem or ciprofloxacin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jan-15, Volume: 38, Issue:2

    Topics: Bacteremia; beta-Lactamases; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome

2004
Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella.
    JAMA, 1998, Oct-14, Volume: 280, Issue:14

    Topics: Adult; Cephalosporin Resistance; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Drug Utilization Review; Guideline Adherence; Hospital Bed Capacity, 500 and over; Hospitals, Community; Humans; Imipenem; Incidence; Infection Control; Klebsiella; Klebsiella Infections; New York City; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins

1998

Other Studies

176 other study(ies) available for imipenem, anhydrous and Infections, Klebsiella

ArticleYear
Detection of a new SHV-type extended-spectrum beta-lactamase, SHV-31, in a Klebsiella pneumoniae strain causing a large nosocomial outbreak in The Netherlands.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Humans; Intensive Care Units; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Netherlands; Plasmids

2007
Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Hospitals; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology

2007
Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2

    Topics: Adult; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Female; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids

2008
Genetic structures at the origin of acquisition of the beta-lactamase bla KPC gene.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:4

    Topics: Base Sequence; beta-Lactamases; beta-Lactams; Cloning, Molecular; Colombia; DNA Transposable Elements; Greece; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA; United States

2008
Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:7

    Topics: Aged; Bacterial Proteins; Base Sequence; beta-Lactamases; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Quinolones; United States

2008
Molecular characterization and epidemiology of extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates causing health care-associated infection in Thailand, where the CTX-M family is endemic.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Adult; Bacterial Proteins; beta-Lactamases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Endemic Diseases; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Polymerase Chain Reaction; Sequence Analysis, DNA; Thailand

2008
Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Genetic; Turkey

2008
Plasmid-encoded carbapenem-hydrolyzing beta-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:9

    Topics: Adult; Anti-Bacterial Agents; Belgium; beta-Lactamases; beta-Lactams; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids

2008
Molecular and biochemical characterization of SHV-56, a novel inhibitor-resistant beta-lactamase from Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:10

    Topics: Aged; Amino Acid Substitution; Base Sequence; beta-Lactam Resistance; beta-Lactamases; DNA Primers; DNA, Bacterial; Female; Genes, Bacterial; Humans; Isoelectric Point; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutagenesis, Insertional; Recombinant Proteins

2008
Genetic organization of transposase regions surrounding blaKPC carbapenemase genes on plasmids from Klebsiella strains isolated in a New York City hospital.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:5

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; DNA Transposable Elements; Drug Resistance, Bacterial; Hospitals, Urban; Humans; Isoenzymes; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Microbial Sensitivity Tests; New York City; Plasmids; Transposases

2009
Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:10

    Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Molecular Sequence Data; Poland

2009
Nonclonal emergence of colistin-resistant Klebsiella pneumoniae isolates from blood samples in South Korea.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Colistin; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Population Surveillance; Republic of Korea

2010
Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Carboxylic Ester Hydrolases; Cefotaxime; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; India; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Penicillins; Sequence Analysis, DNA; Sequence Homology, Amino Acid

2009
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Culture Media; Defensins; DNA, Bacterial; Drug Resistance, Bacterial; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Lipopolysaccharides; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Phenotype; Plasmids; Polymyxin B; Polysaccharides; Repressor Proteins; RNA, Bacterial

2010
KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:5

    Topics: Aged; beta-Lactamases; Diabetic Nephropathies; Humans; Kidney Failure, Chronic; Klebsiella Infections; Klebsiella pneumoniae; Male; Renal Dialysis; Republic of Korea

2010
Molecular epidemiology, sequence types, and plasmid analyses of KPC-producing Klebsiella pneumoniae strains in Israel.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Humans; Israel; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Phylogeny; Plasmids; Polymerase Chain Reaction

2010
Incidence and antimicrobial susceptibility of Escherichia coli and Klebsiella pneumoniae with extended-spectrum beta-lactamases in community- and hospital-associated intra-abdominal infections in Europe: results of the 2008 Study for Monitoring Antimicrob
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:7

    Topics: Abdomen; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Escherichia coli; Escherichia coli Infections; Humans; Klebsiella Infections; Klebsiella pneumoniae

2010
Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftazidime; Disease Models, Animal; Female; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Sepsis

2011
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction

2011
Total Synthesis and Structure-Activity Relationships Study of Odilorhabdins, a New Class of Peptides Showing Potent Antibacterial Activity.
    Journal of medicinal chemistry, 2018, 09-13, Volume: 61, Issue:17

    Topics: Animals; Anti-Bacterial Agents; Humans; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Molecular Structure; Peptide Fragments; Protein Biosynthesis; Respiratory Tract Infections; Ribosome Subunits, Small; Structure-Activity Relationship; Xenorhabdus

2018
Factors behind the prevalence of carbapenem-resistant Klebsiella pneumoniae in pediatric wards.
    Medicine, 2021, Sep-10, Volume: 100, Issue:36

    Topics: Adult; Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Child; Child, Preschool; China; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Male; Maternal-Child Health Services; Pregnancy

2021
Antibiogram and molecular characterization of multi-drug resistant microorganisms isolated from urinary tract infections.
    Pakistan journal of pharmaceutical sciences, 2021, Volume: 34, Issue:3(Suppleme

    Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nitrofurantoin; Oxacillin; Pakistan; Pipemidic Acid; Piperacillin, Tazobactam Drug Combination; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2021
New options for bloodstream infections caused by colistin- or ceftazidime/avibactam-resistant Klebsiella pneumoniae.
    International journal of antimicrobial agents, 2021, Volume: 58, Issue:6

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacteremia; beta-Lactamase Inhibitors; Boronic Acids; Carbapenem-Resistant Enterobacteriaceae; Ceftazidime; Cilastatin; Colistin; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Tetracyclines

2021
Machine learning for identifying resistance features of
    Journal of medical microbiology, 2021, Volume: 70, Issue:11

    Topics: Amikacin; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Genome, Bacterial; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Machine Learning; Microbial Sensitivity Tests; Polymorphism, Single Nucleotide; Tetracyclines

2021
In vitro activity of imipenem-relebactam against KPC-producing Klebsiella pneumoniae resistant to ceftazidime-avibactam and/or meropenem-vaborbactam.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022, Volume: 28, Issue:5

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Boronic Acids; Ceftazidime; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests

2022
Prevalence and antibiotic resistance of
    The Journal of international medical research, 2022, Volume: 50, Issue:2

    Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Prevalence; Tertiary Care Centers

2022
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments.
    The Journal of antimicrobial chemotherapy, 2022, 05-29, Volume: 77, Issue:6

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cilastatin; Drug Combinations; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2022
Carbapenem antibiotic stress increases bla
    Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; DNA Copy Number Variations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2022
Extended-spectrum beta-lactamases among Klebsiella pneumoniae from Iraqi patients with community-acquired pneumonia.
    Revista da Associacao Medica Brasileira (1992), 2022, Volume: 68, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; Humans; Imipenem; Iraq; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Norfloxacin; Pneumonia

2022
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections.
    Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:9

    Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2022
High-level ertapenem resistance in Klebsiella pneumoniae is due to RamA downregulation of ompK35 through micF.
    International journal of antimicrobial agents, 2022, Volume: 60, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Down-Regulation; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sodium Dodecyl Sulfate

2022
    Antimicrobial agents and chemotherapy, 2022, 10-18, Volume: 66, Issue:10

    Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; Carbapenems; Ceftazidime; Cephalosporins; Drug Combinations; Escherichia coli; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests

2022
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.
    Current microbiology, 2022, Oct-15, Volume: 79, Issue:12

    Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Colistin; Croatia; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests

2022
Molecular characteristics and genetic analysis of the genes related to carbapenemase, efflux pump, and outer membrane proteins in carbapenem-resistant Klebsiella pneumoniae.
    Letters in applied microbiology, 2023, Feb-16, Volume: 76, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Multilocus Sequence Typing; Porins

2023
Analysis of risk factors associated with healthcare-associated carbapenem-resistant Klebsiella pneumoniae infection in a large general hospital: a case-case-control study.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2023, Volume: 42, Issue:5

    Topics: Anti-Bacterial Agents; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cross Infection; Delivery of Health Care; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors

2023
Carbapenem Resistance among Klebsiella pneumoniae in a Tertiary Care Hospital in Bangladesh.
    Mymensingh medical journal : MMJ, 2023, Volume: 32, Issue:2

    Topics: Agar; Anti-Bacterial Agents; Bangladesh; beta-Lactamases; Carbapenems; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tertiary Care Centers

2023
In vitro activity of imipenem/relebactam and ceftazidime/avibactam against carbapenem-resistant Klebsiella pneumoniae from blood cultures in a University hospital in Serbia.
    Acta microbiologica et immunologica Hungarica, 2023, Sep-21, Volume: 70, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Ceftazidime; Colistin; Drug Combinations; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Serbia

2023
Occurrence of some common carbapenemase genes in carbapenem-resistant Klebsiella pneumoniae isolates collected from clinical samples in Tabriz, northwestern Iran.
    BMC research notes, 2023, Nov-03, Volume: 16, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Cross-Sectional Studies; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests

2023
The Occurrence of bla
    Infectious disorders drug targets, 2020, Volume: 20, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Nalidixic Acid; Trimethoprim, Sulfamethoxazole Drug Combination

2020
Multidrug-resistant Klebsiella pneumoniae in hospital-acquired infections: Concomitant analysis of antimicrobial resistant strains.
    International journal of clinical practice, 2020, Volume: 74, Issue:4

    Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Child; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Phenotype; Young Adult

2020
Molecular-diversity, Prevalence and Antibiotic Susceptibility of Pathogenic Klebsiella Pneumoniae under Saudi Condition.
    Pakistan journal of biological sciences : PJBS, 2019, Volume: 22, Issue:4

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cefotaxime; Ceftazidime; Ceftriaxone; DNA, Bacterial; Female; Genetic Variation; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Saudi Arabia; Virulence

2019
Klebsiella pneumoniae carbapenemase (KPC) producer resistant to ceftazidime-avibactam due to a deletion in the blaKPC3 gene.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2020, Volume: 26, Issue:7

    Topics: Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sequence Analysis, DNA; Sequence Deletion

2020
Efflux pump activity, biofilm formation and antibiotic resistance profile of Klebsiella spp. isolated from clinical samples at Lagos University Teaching Hospital.
    BMC research notes, 2020, May-26, Volume: 13, Issue:1

    Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Biofilms; Cefuroxime; Cells, Cultured; Community-Acquired Infections; Drug Combinations; Drug Resistance, Multiple, Bacterial; Hospitals, Teaching; Hospitals, University; Humans; Imipenem; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests; Nigeria; Ofloxacin; Tertiary Care Centers

2020
First description of antimicrobial resistance in carbapenem-susceptible Klebsiella pneumoniae after imipenem treatment, driven by outer membrane remodeling.
    BMC microbiology, 2020, 07-20, Volume: 20, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Plasmids; Virulence Factors; Whole Genome Sequencing

2020
Geographical distribution of Enterobacterales with a carbapenemase IMP-6 phenotype and its association with antimicrobial use: An analysis using comprehensive national surveillance data on antimicrobial resistance.
    PloS one, 2020, Volume: 15, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Phenotype

2020
[Analysis of related factors of carbapenem resistant Klebsiella pneumoniae infection in patients with artificial airway].
    Zhonghua wei zhong bing ji jiu yi xue, 2020, Volume: 32, Issue:11

    Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Risk Factors

2020
Antibacterial activity and carbapenem re-sensitizing ability of 1,10-phenanthroline-5,6-dione and its metal complexes against KPC-producing Klebsiella pneumoniae clinical strains.
    Letters in applied microbiology, 2021, Volume: 73, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Coordination Complexes; Drug Resistance, Multiple, Bacterial; Drug Synergism; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenanthrolines

2021
Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2021, 08-17, Volume: 65, Issue:9

    Topics: Anti-Bacterial Agents; Bacteriophages; beta-Lactamases; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mitomycin

2021
Clinical Characteristics, Risk Factors, and Outcomes of Patients with Polymicrobial
    BioMed research international, 2021, Volume: 2021

    Topics: Adult; Aged; Bacteremia; Carbapenems; Ertapenem; Female; Hospitalization; Humans; Imipenem; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome

2021
Identification of IS1R and IS10R elements inserted into ompk36 porin gene of two multidrug-resistant Klebsiella pneumoniae hospital strains.
    FEMS microbiology letters, 2017, 05-01, Volume: 364, Issue:10

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cloning, Molecular; Databases, Genetic; DNA Transposable Elements; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Imipenem; Integrons; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins; Sequence Analysis, DNA

2017
Emergence of the Plasmid-Mediated
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:7

    Topics: Anti-Bacterial Agents; beta-Lactamases; Brazil; Colistin; Drug Resistance, Bacterial; Escherichia coli Proteins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Plasmids

2017
Bacterial zincophore [S,S]-ethylenediamine-N,N'-disuccinic acid is an effective inhibitor of MBLs.
    The Journal of antimicrobial chemotherapy, 2018, 02-01, Volume: 73, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Disease Models, Animal; Enzyme Inhibitors; Ethylenediamines; Gram-Negative Bacteria; Imipenem; Klebsiella Infections; Lepidoptera; Microbial Sensitivity Tests; Succinates; Survival Analysis; Treatment Outcome

2018
Update of incidence and antimicrobial susceptibility trends of Escherichia coli and Klebsiella pneumoniae isolates from Chinese intra-abdominal infection patients.
    BMC infectious diseases, 2017, 12-18, Volume: 17, Issue:1

    Topics: Abdomen; Anti-Bacterial Agents; beta-Lactams; Cephalosporins; China; Community-Acquired Infections; Cross Infection; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Incidence; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2017
An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Disease Outbreaks; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Porins; Tunisia

2018
High Prevalence of CTX-M-15-Type Extended-Spectrum β-Lactamase Among AmpC β-Lactamase-Producing Klebsiella pneumoniae Isolates Causing Bacteremia in Korea.
    Microbial drug resistance (Larchmont, N.Y.), 2018, Volume: 24, Issue:7

    Topics: Bacteremia; Bacterial Proteins; beta-Lactamases; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Epidemiology; Plasmids; Republic of Korea

2018
Genetic and Biochemical Characterization of OXA-519, a Novel OXA-48-Like β-Lactamase.
    Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8

    Topics: Aged, 80 and over; Amino Acid Substitution; Anti-Bacterial Agents; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Ertapenem; Humans; Hydrolysis; Imipenem; Isoenzymes; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutagenesis, Insertional; Plasmids; Sequence Deletion

2018
Molecular epidemiology of ESBL-producing Klebsiella pneumoniae isolates in intensive care units of a tertiary care hospital, North of Iran.
    Cellular and molecular biology (Noisy-le-Grand, France), 2018, May-30, Volume: 64, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Child; Child, Preschool; Clavulanic Acid; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Intensive Care Units; Iran; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Nalidixic Acid; Tertiary Care Centers

2018
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
    JPMA. The Journal of the Pakistan Medical Association, 2018, Volume: 68, Issue:6

    Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam

2018
Elucidating the survival and response of carbapenem resistant Klebsiella pneumoniae after exposure to imipenem at sub-lethal concentrations.
    Pathogens and global health, 2018, Volume: 112, Issue:7

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phenotype

2018
Degradable antimicrobial polycarbonates with unexpected activity and selectivity for treating multidrug-resistant Klebsiella pneumoniae lung infection in mice.
    Acta biomaterialia, 2019, Volume: 94

    Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biocompatible Materials; Cell Line; Cell Membrane; Cytosol; Drug Resistance, Multiple, Bacterial; Epithelial Cells; Female; Guanidine; Humans; Imipenem; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lung Diseases; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Microbial Sensitivity Tests; Pneumonia, Bacterial; Polycarboxylate Cement; Polymers; Protein Binding

2019
Comparison of adhesin genes expression among Klebsiella oxytoca ESBL-non-producers in planktonic and biofilm mode of growth, and imipenem sublethal exposure.
    Microbial pathogenesis, 2019, Volume: 134

    Topics: Adhesins, Bacterial; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Biofilms; Carbapenems; Gene Expression Regulation, Bacterial; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Phenotype

2019
Treatment with andrographolide sulfonate provides additional benefits to imipenem in a mouse model of Klebsiella pneumoniae pneumonia.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 117

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; Cell Movement; Disease Models, Animal; Diterpenes; Humans; Imipenem; Inflammation; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice, Inbred C57BL; Monocyte Chemoattractant Proteins; NLR Family, Pyrin Domain-Containing 3 Protein; Pneumonia; Survival Analysis; THP-1 Cells

2019
Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: improving reliability for the double carbapenemase producers.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2013, Volume: 19, Issue:9

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cloxacillin; Europe; Greece; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Picolinic Acids; Reproducibility of Results; Thienamycins

2013
Meropenem resistance in imipenem-susceptible meropenem-resistant Klebsiella pneumoniae isolates not detected by rapid automated testing systems.
    Journal of clinical microbiology, 2013, Volume: 51, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Diagnostic Errors; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins

2013
In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
    Diagnostic microbiology and infectious disease, 2013, Volume: 76, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Colistin; Disk Diffusion Antimicrobial Tests; Drug Synergism; Fosfomycin; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Minocycline; Molecular Typing; Real-Time Polymerase Chain Reaction; Thienamycins; Tigecycline

2013
Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.
    Acta microbiologica et immunologica Hungarica, 2013, Volume: 60, Issue:2

    Topics: Anti-Bacterial Agents; Ceftazidime; Colistin; Drug Resistance, Bacterial; Drug Synergism; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Tobramycin

2013
The first case of septicemia caused by imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae.
    Annals of laboratory medicine, 2013, Volume: 33, Issue:5

    Topics: Aged; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Phenotype; Sepsis; Thienamycins

2013
[Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures].
    Mikrobiyoloji bulteni, 2013, Volume: 47, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Cefotaxime; Cefoxitin; Ceftazidime; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Plasmids

2013
Activity of imipenem against Klebsiella pneumoniae biofilms in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Biofilms; Dermis; Ear; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Rabbits; Re-Epithelialization

2014
Risk factors associated with preoperative fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae in liver transplant recipients.
    Transplant infectious disease : an official journal of the Transplantation Society, 2014, Volume: 16, Issue:1

    Topics: Adult; Amikacin; beta-Lactamases; beta-Lactams; Cefoxitin; Ciprofloxacin; Drug Resistance, Bacterial; End Stage Liver Disease; Enterobacter cloacae; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Feces; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Preoperative Period; Risk Factors; Severity of Illness Index

2014
Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:7

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Female; Genome, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Polymerase Chain Reaction; Public Health Surveillance; Survival Analysis; Thienamycins; Treatment Outcome

2014
Molecular epidemiology of OXA-48-producing Klebsiella pneumoniae in France.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2014, Volume: 20, Issue:12

    Topics: Anti-Bacterial Agents; beta-Lactamases; Electrophoresis, Gel, Pulsed-Field; France; Genotype; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Molecular Epidemiology; Multilocus Sequence Typing; Thienamycins

2014
Increasing resistance rate to carbapenem among blood culture isolates of Klebsiella pneumoniae, Acinetobacter baumannii and Pseudomonas aeruginosa in a university-affiliated hospital in China, 2004-2011.
    The Journal of antibiotics, 2015, Volume: 68, Issue:2

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Carbapenems; Cephalosporins; China; Drug Resistance, Bacterial; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Thienamycins

2015
Endogenous endophthalmitis complicated by pyogenic liver abscess: a review of 17 years' experience at a single center.
    Digestion, 2014, Volume: 90, Issue:2

    Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Diabetes Complications; Endophthalmitis; Female; Humans; Imipenem; Incidence; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Male; Middle Aged; Risk Factors; Treatment Outcome

2014
First report in China of Enterobacteriaceae clinical isolates coharboring blaNDM-1 and blaIMP-4 drug resistance genes.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:2

    Topics: Adolescent; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; China; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Plasmids; Quinolones; Thienamycins

2015
Pharmacodynamics of imipenem in combination with β-lactamase inhibitor MK7655 in a murine thigh model.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:2

    Topics: Animals; beta-Lactamase Inhibitors; Disease Models, Animal; Female; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Thigh

2015
Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    American journal of infection control, 2014, Volume: 42, Issue:12

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Containment of Biohazards; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Imipenem; Incidence; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phenotype; Prevalence; Prospective Studies; Republic of Korea; Retrospective Studies; Thienamycins

2014
Characterization of extended-spectrum beta-lactamase, carbapenemase, and plasmid quinolone determinants in Klebsiella pneumoniae isolates carrying distinct types of 16S rRNA methylase genes, and their association with mobile genetic elements.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:2

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; China; Conjugation, Genetic; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Humans; Imipenem; Integrons; Interspersed Repetitive Sequences; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Quinolones; RNA, Ribosomal, 16S; tRNA Methyltransferases

2015
Approved Drugs Containing Thiols as Inhibitors of Metallo-β-lactamases: Strategy To Combat Multidrug-Resistant Bacteria.
    Journal of medicinal chemistry, 2015, Apr-23, Volume: 58, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Crystallography, X-Ray; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Models, Molecular; Pseudomonas aeruginosa; Pseudomonas Infections; Sulfhydryl Compounds

2015
The Role of OmpK35, OmpK36 Porins, and Production of β-Lactamases on Imipenem Susceptibility in Klebsiella pneumoniae Clinical Isolates, Cairo, Egypt.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cefoxitin; Egypt; Gene Expression Regulation, Bacterial; Hospitals, University; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins

2015
In Vitro Activity of Imipenem and Colistin against a Carbapenem-Resistant Klebsiella pneumoniae Isolate Coproducing SHV-31, CMY-2, and DHA-1.
    BioMed research international, 2015, Volume: 2015

    Topics: Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Hip; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Porins

2015
Trends in Susceptibility Rates and Extended-Spectrum β-Lactamase Production of Klebsiella pneumoniae in Bloodstream Infections Across the United States Veterans Affairs Healthcare System.
    Microbial drug resistance (Larchmont, N.Y.), 2015, Volume: 21, Issue:6

    Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Cefepime; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Ertapenem; Fluoroquinolones; Gene Expression Regulation, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sulbactam; United States; United States Department of Veterans Affairs

2015
Efficacy of Appropriate Antimicrobial Therapy on the Survival of Patients With Carbapenem Nonsusceptible Klebsiella Pneumoniae Infection: A Multicenter Study in Taiwan.
    Medicine, 2015, Volume: 94, Issue:33

    Topics: Aged; Anti-Infective Agents; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Medication Therapy Management; Meropenem; Microbial Sensitivity Tests; Middle Aged; Outcome Assessment, Health Care; Pneumonia; Proportional Hazards Models; Severity of Illness Index; Taiwan; Thienamycins

2015
Biochemical Characterization of VIM-39, a VIM-1-Like Metallo-β-Lactamase Variant from a Multidrug-Resistant Klebsiella pneumoniae Isolate from Greece.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:12

    Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactam Resistance; beta-Lactamases; Biotransformation; Cephalothin; Gene Expression; Greece; Humans; Hydrolysis; Imipenem; Isoenzymes; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Sequence Analysis, DNA

2015
EMERGENCY ROOM: AN UNRECOGNIZED SOURCE OF EXTENDED-SPECTRUM β-LACTAMASE PRODUCING ESCHERICHIA COLI AND KLEBSIELLA PNEUMONIAE.
    The Southeast Asian journal of tropical medicine and public health, 2015, Volume: 46, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cross Infection; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Plasmids; Thailand; Thienamycins; Young Adult

2015
Identification and Characterization of Imipenem-Resistant Klebsiella pneumoniae and Susceptible Klebsiella variicola Isolates Obtained from the Same Patient.
    Microbial drug resistance (Larchmont, N.Y.), 2016, Volume: 22, Issue:3

    Topics: Aged; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Phylogeny; Virulence Factors

2016
Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2016, Volume: 49, Issue:4

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Blood; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Nursing Homes; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus Infections; Proteus mirabilis; Retrospective Studies; Sputum; Taiwan; Thienamycins; Urine

2016
Combination Regimens for Treatment of Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cephalosporins; Drug Therapy, Combination; Female; Humans; Imipenem; Immunosuppressive Agents; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Retrospective Studies; Survival Analysis; Thienamycins; Treatment Outcome

2016
Emergence and interhospital spread of OXA-48-producing Klebsiella pneumoniae ST395 clone in Western Hungary.
    Infectious diseases (London, England), 2017, Volume: 49, Issue:3

    Topics: beta-Lactamases; Cross Infection; Genotype; Hospitals; Humans; Hungary; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Typing; Thienamycins

2017
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
    Enfermedades infecciosas y microbiologia clinica, 2017, Volume: 35, Issue:8

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult

2017
Successful Treatment of Urinary Tract Infection in Kidney Transplant Recipients Caused by Multiresistant Klebsiella pneumoniae Producing New Delhi Metallo-Beta-Lactamase (NDM-1) With Strains Genotyping.
    Transplantation proceedings, 2016, Volume: 48, Issue:5

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cilastatin; Cilastatin, Imipenem Drug Combination; Colistin; Drug Combinations; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Fosfomycin; Genotype; Gentamicins; Humans; Imipenem; Kidney Transplantation; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Transplant Recipients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections

2016
High minimum inhibitory concentration of imipenem as a predictor of fatal outcome in patients with carbapenem non-susceptible Klebsiella pneumoniae.
    Scientific reports, 2016, 09-02, Volume: 6

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Female; Hospitals, General; Hospitals, Veterans; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Analysis; Taiwan; Treatment Outcome; Young Adult

2016
Clonal Spread of Colistin-Resistant Klebsiella pneumoniae Coproducing KPC and VIM Carbapenemases in Neonates at a Tunisian University Hospital.
    Microbial drug resistance (Larchmont, N.Y.), 2017, Volume: 23, Issue:4

    Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactamases; beta-Lactams; Chloramphenicol; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Female; Gene Expression; Hospitals, University; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Minocycline; Retrospective Studies; Survival Analysis; Tigecycline; Tunisia

2017
Antibiotic Sensitivity pattern of Bacterial Isolates of Neonatal Septicemia in Peshawar, Pakistan.
    Archives of Iranian medicine, 2016, Volume: 19, Issue:12

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Enoxacin; Escherichia coli; Escherichia coli Infections; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Low Birth Weight; Infant, Newborn; Klebsiella; Klebsiella Infections; Male; Microbial Sensitivity Tests; Neonatal Sepsis; Ofloxacin; Pakistan; Proteus; Proteus Infections; Pseudomonas; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis

2016
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009.
    Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Critical Care; Doripenem; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Gene Expression; Genotype; Humans; Imipenem; Klebsiella; Klebsiella Infections; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Thienamycins; United States

2017
Emergence of Serratia liquefaciens and Klebsiella oxytoca with metallo-beta-lactamase-encoding IncW plasmids: further spread of the blaVIM-1-carrying integron In-e541.
    International journal of antimicrobial agents, 2008, Volume: 32, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactamases; Biomarkers; Conjugation, Genetic; Drug Resistance, Bacterial; Greece; Humans; Imipenem; Integrons; Klebsiella Infections; Klebsiella oxytoca; Microbial Sensitivity Tests; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Serratia Infections; Serratia liquefaciens

2008
Combined porin loss and extended spectrum beta-lactamase production is associated with an increasing imipenem minimal inhibitory concentration in clinical Klebsiella pneumoniae strains.
    Current microbiology, 2009, Volume: 58, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; China; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Porins

2009
Clinical outcomes of patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae after treatment with imipenem or meropenem.
    Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Female; Genes, Bacterial; Humans; Imipenem; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Polymerase Chain Reaction; Thienamycins; Treatment Failure; Treatment Outcome; Young Adult

2009
Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at Armed Forces Hospital in Saudi Arabia.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2009, Volume: 19, Issue:4

    Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Prevalence; Saudi Arabia; Tetracycline Resistance

2009
Clinical outcomes of spontaneous bacterial peritonitis due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: a retrospective matched case-control study.
    BMC infectious diseases, 2009, Apr-12, Volume: 9

    Topics: Aged; Anti-Bacterial Agents; Ascites; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Cephalosporins; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella; Klebsiella Infections; Liver Cirrhosis; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Treatment Failure

2009
The prevalence of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae among clinical isolates from a general hospital in Iran.
    Acta microbiologica et immunologica Hungarica, 2009, Volume: 56, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Female; Hospitals, General; Humans; Imipenem; Iran; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Prevalence

2009
Characterization of multidrug-resistant and extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strains from Malaysian hospitals.
    Journal of medical microbiology, 2009, Volume: 58, Issue:Pt 11

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Conjugation, Genetic; Cross Infection; DNA Fingerprinting; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hospitals, Public; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction

2009
First isolation of a VIM-producing Klebsiella pneumoniae from a seven-year-old child in Venezuela.
    Journal of infection in developing countries, 2008, Jun-01, Volume: 2, Issue:3

    Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Child; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Quinolones; Thienamycins; Urine; Venezuela

2008
In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase.
    International journal of antimicrobial agents, 2010, Volume: 35, Issue:3

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; beta-Lactamases; DNA Fingerprinting; DNA, Bacterial; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Plasmids; Selection, Genetic

2010
Imipenem-associated encephalopathy: alert to physicians.
    Arquivos de neuro-psiquiatria, 2010, Volume: 68, Issue:1

    Topics: Aged; Anti-Bacterial Agents; Brain Diseases; Humans; Imipenem; Klebsiella Infections; Male; Sepsis

2010
The ongoing challenge of acquired carbapenemases: a hospital outbreak of Klebsiella pneumoniae simultaneously producing VIM-1 and KPC-2.
    International journal of antimicrobial agents, 2010, Volume: 36, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Disease Outbreaks; Greece; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Thienamycins

2010
Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.
    Yonsei medical journal, 2010, Volume: 51, Issue:6

    Topics: Acinetobacter; Bacterial Infections; Ceftazidime; Cross Infection; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Methicillin-Resistant Staphylococcus aureus; Pseudomonas aeruginosa; Republic of Korea; Vancomycin

2010
Severe systemic sepsis due to pyogenic liver abscess.
    Irish journal of medical science, 2012, Volume: 181, Issue:2

    Topics: Anti-Bacterial Agents; Ciprofloxacin; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Liver Abscess, Pyogenic; Male; Middle Aged; Sepsis

2012
[Iatrogenic meningitis after diagnosis lumbar puncture: 3 cases reports in the paediatric Children's Hospital of Tunis].
    Bulletin de la Societe de pathologie exotique (1990), 2011, Volume: 104, Issue:1

    Topics: beta-Lactam Resistance; Brain Abscess; Brain Damage, Chronic; Ciprofloxacin; Drug Therapy, Combination; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fosfomycin; Humans; Hydrocephalus; Iatrogenic Disease; Imipenem; Infant; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Klebsiella Infections; Klebsiella pneumoniae; Male; Meningitis, Bacterial; Muscle Hypotonia; Seizures; Serratia Infections; Serratia marcescens; Spinal Puncture; Subdural Effusion; Tunisia

2011
Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Bacterial Load; beta-Lactamases; Carbapenems; Cytokines; Disease Models, Animal; Doripenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Mice; Mice, Inbred C3H; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Treatment Outcome

2011
Extended measures for controlling an outbreak of VIM-1 producing imipenem-resistant Klebsiella pneumoniae in a liver transplant centre in France, 2003-2004.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2010, Nov-18, Volume: 15, Issue:46

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Drug Resistance, Bacterial; Female; France; Hospital Bed Capacity, 500 and over; Humans; Imipenem; Infection Control; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Microbial Sensitivity Tests

2010
Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae.
    Southern medical journal, 2011, Volume: 104, Issue:2

    Topics: Age Factors; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Case-Control Studies; Chi-Square Distribution; Confidence Intervals; Cross Infection; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Risk Factors; Thienamycins

2011
Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
    Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:2

    Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Typing Techniques; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; DNA, Bacterial; Doripenem; Electrophoresis, Gel, Pulsed-Field; Ertapenem; Genotype; Hospitals, Urban; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Phylogeny; Polymerase Chain Reaction; Sensitivity and Specificity; Thienamycins; United States

2011
[Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:1

    Topics: Amikacin; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella oxytoca; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Thienamycins

2011
Sepsis in neonates due to imipenem-resistant Klebsiella pneumoniae producing NDM-1 in India.
    The Journal of antimicrobial chemotherapy, 2011, Volume: 66, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Humans; Imipenem; India; Infant, Newborn; Intensive Care Units; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Sepsis

2011
Carbapenem therapy for bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Diagnostic microbiology and infectious disease, 2011, Volume: 70, Issue:1

    Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome

2011
Evaluation of a real-time PCR assay for the detection of the Klebsiella pneumoniae carbapenemase genes in microbiological samples in comparison with the modified Hodge test.
    American journal of clinical pathology, 2011, Volume: 135, Issue:4

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; DNA, Bacterial; Ertapenem; Genes, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Polymerase Chain Reaction; Predictive Value of Tests

2011
Susceptibility of Klebsiella pneumoniae isolates from intra-abdominal infections and molecular characterization of ertapenem-resistant isolates.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:8

    Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Humans; Imipenem; Intraabdominal Infections; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2011
Emergence in Japan of an imipenem-susceptible, meropenem-resistant Klebsiella pneumoniae carrying blaIMP-6.
    Diagnostic microbiology and infectious disease, 2012, Volume: 72, Issue:1

    Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Female; Gene Transfer, Horizontal; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Plasmids; Thienamycins

2012
Rapid detection of blaIMP-6 by amplification refractory mutation system.
    Journal of microbiological methods, 2012, Volume: 88, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Drug Resistance, Bacterial; Humans; Imipenem; Japan; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction

2012
Efficacy of imipenem for the treatment of bacteremia due to an OXA-48-producing Klebsiella pneumoniae isolate.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2012, Feb-15, Volume: 54, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; DNA, Bacterial; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Treatment Outcome

2012
Characterization of a novel Klebsiella pneumoniae sequence type 476 carrying both bla KPC-2 and bla IMP-4.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Blotting, Southern; China; Electrophoresis, Gel, Pulsed-Field; Female; Genotype; Humans; Imipenem; Infant; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Multilocus Sequence Typing; Plasmids; Polymerase Chain Reaction; Sequence Analysis, DNA; Thienamycins; Urine

2012
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate

2012
Novel modeling framework to guide design of optimal dosing strategies for β-lactamase inhibitors.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:5

    Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; Computer Simulation; Drug Administration Schedule; Drug Combinations; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Membranes, Artificial; Microbial Sensitivity Tests; Models, Statistical; Practice Guidelines as Topic

2012
Carbapenem therapy for bacteremia due to extended-spectrum-β-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility.
    Antimicrobial agents and chemotherapy, 2012, Volume: 56, Issue:6

    Topics: Adult; Bacteremia; beta-Lactams; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Retrospective Studies; Thienamycins; Young Adult

2012
A 9-Year retrospective review of antibiotic cycling in a surgical intensive care unit.
    The Journal of surgical research, 2012, Volume: 176, Issue:2

    Topics: Anti-Bacterial Agents; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Critical Care; Cross Infection; Drug Combinations; Drug Resistance, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infection Control; Klebsiella Infections; Klebsiella pneumoniae; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Surgical Wound Infection

2012
Sequence type 101 (ST101) as the predominant carbapenem-non-susceptible Klebsiella pneumoniae clone in an acute general hospital in Italy.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:6

    Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Hospitals, General; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2012
Occurrence and phenotypic detection of class A carbapenemases among Escherichia coli and Klebsiella pneumoniae blood isolates at a tertiary care center.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2013, Volume: 46, Issue:2

    Topics: Adult; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cross Infection; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Prevalence; Sepsis; Tertiary Care Centers; Thienamycins

2013
Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:10

    Topics: beta-Lactamases; beta-Lactams; Disease Outbreaks; Ertapenem; Genes, Bacterial; Hospitals; Humans; Imipenem; Ireland; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Polymerase Chain Reaction; Thienamycins

2012
Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012.
    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2012, Aug-16, Volume: 17, Issue:33

    Topics: Anti-Bacterial Agents; Carbapenems; Drug Resistance, Bacterial; Hospitals; Humans; Imipenem; Italy; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Sentinel Surveillance; Thienamycins

2012
Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009.
    Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 1

    Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Population Surveillance; Taiwan

2013
Epidemiology and resistance mechanisms to imipenem in Klebsiella pneumoniae: a multicenter study.
    Molecular medicine reports, 2013, Volume: 7, Issue:1

    Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Cephalosporinase; Electrophoresis, Gel, Pulsed-Field; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2013
[Comparison of ertapenem-EMB Agar with traditional methods for screening carbapenem-resistant Klebsiella pneumoniae from rectal swabs].
    Mikrobiyoloji bulteni, 2012, Volume: 46, Issue:4

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Culture Media; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Multiplex Polymerase Chain Reaction; Rectum; Sensitivity and Specificity; Thienamycins; Time Factors

2012
[Distribution of bacteria and analysis of their sensibility to antibiotics in patients with hospital-acquired pneumonia].
    Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 2000, Dec-28, Volume: 25, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Cefoperazone; Ceftriaxone; Cross Infection; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus epidermidis

2000
Attributable costs and length of stay of an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae outbreak in a neonatal intensive care unit.
    Infection control and hospital epidemiology, 2003, Volume: 24, Issue:8

    Topics: Anti-Bacterial Agents; beta-Lactamases; Cross Infection; Disease Outbreaks; Hospital Costs; Humans; Imipenem; Infant, Newborn; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Length of Stay; New York City; Sentinel Surveillance

2003
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Jul-01, Volume: 39, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Drug Resistance, Bacterial; Drug Utilization; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Multivariate Analysis

2004
Comparison of trends of resistance rates over 3 years calculated from results for all isolates and for the first isolate of a given species from a patient.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:10

    Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Cefotaxime; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Time Factors

2004
First isolation of metallo-beta-lactamase-producing multiresistant Klebsiella pneumoniae from a patient in Brazil.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:1

    Topics: Aged; Anti-Bacterial Agents; beta-Lactamases; Brazil; Drug Resistance, Multiple, Bacterial; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests

2005
Activity of cefepime and carbapenems in experimental pneumonia caused by porin-deficient Klebsiella pneumoniae producing FOX-5 beta-lactamase.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:1

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Colony Count, Microbial; Guinea Pigs; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Thienamycins; Treatment Outcome

2005
Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Disease Models, Animal; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Pneumonia, Bacterial; Porins; Treatment Outcome

2005
In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Conjugation, Genetic; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Infant; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Plasmids; Selection, Genetic

2005
Evaluation of techniques for detection of carbapenem-resistant Klebsiella pneumoniae in stool surveillance cultures.
    Journal of clinical microbiology, 2005, Volume: 43, Issue:11

    Topics: Bacteriological Techniques; Carbapenems; Culture Media; Drug Resistance, Bacterial; Evaluation Studies as Topic; Feces; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests

2005
Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance.
    Yonsei medical journal, 2006, Feb-28, Volume: 47, Issue:1

    Topics: Acinetobacter; Acinetobacter Infections; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Fluoroquinolones; Gammaproteobacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Korea; Microbial Sensitivity Tests; Population Surveillance; Vancomycin; Vancomycin Resistance

2006
Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Colony Count, Microbial; Imipenem; In Vitro Techniques; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Microbial Sensitivity Tests; Plasmids; Pneumonia, Bacterial; Porins; Rats; Rats, Wistar; Thienamycins; Treatment Outcome

2006
Prevalence and mechanisms of decreased susceptibility to carbapenems in Klebsiella pneumoniae isolates.
    Diagnostic microbiology and infectious disease, 2007, Volume: 57, Issue:1

    Topics: Amino Acid Sequence; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Korea; Mass Spectrometry; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Porins; Prevalence; Sequence Analysis, DNA; Thienamycins

2007
[Sanfetrinem, the member of trinems--in vitro activity against Klebsiella pneumoniae producing ESBL].
    Medycyna doswiadczalna i mikrobiologia, 2006, Volume: 58, Issue:1

    Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Drug Resistance, Multiple, Bacterial; Hospitals; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lactams; Microbial Sensitivity Tests

2006
VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases.
    International journal of antimicrobial agents, 2007, Volume: 29, Issue:4

    Topics: Adult; Aged; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Case-Control Studies; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Regression Analysis; Retrospective Studies; Survival Rate; Treatment Outcome

2007
The effect of amikacin and imipenem alone and in combination against an extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Diagnostic microbiology and infectious disease, 2007, Volume: 58, Issue:1

    Topics: Amikacin; Animals; Anti-Bacterial Agents; beta-Lactamases; Drug Synergism; Drug Therapy, Combination; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Microbial Sensitivity Tests

2007
Porin loss and GES-type extended-spectrum beta-lactamase primarily responsible for reduced susceptibility to imipenem.
    Diagnostic microbiology and infectious disease, 2007, Volume: 58, Issue:2

    Topics: Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Porins

2007
Imipenem-resistance in Klebsiella pneumoniae in Malaysia due to loss of OmpK36 outer membrane protein coupled with AmpC hyperproduction.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2007, Volume: 11, Issue:5

    Topics: Adult; Amino Acid Sequence; Bacterial Proteins; Base Sequence; beta-Lactamases; Drug Resistance, Bacterial; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Malaysia; Porins

2007
Ertapenem susceptibility of extended spectrum beta-lactamase-producing organisms.
    Annals of clinical microbiology and antimicrobials, 2007, Jun-06, Volume: 6

    Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Military Personnel

2007
Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8

    Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Intestines; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination

2007
Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
    The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:2

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; beta-Lactams; Cephalosporins; Conjugation, Genetic; DNA, Bacterial; Drug Resistance, Bacterial; Electroporation; Ertapenem; Female; Genotype; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Porins; Reverse Transcriptase Polymerase Chain Reaction; Thienamycins

2007
[Antibiotic susceptibility and molecular mechanisms of cephalosporins resistance in Klebsiella isolates from patients with hospital-acquired infections].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2006, Volume: 51, Issue:11-12

    Topics: Anti-Bacterial Agents; Carbapenems; Cephalosporin Resistance; Cross Infection; Humans; Imipenem; Klebsiella; Klebsiella Infections; Meropenem; Thienamycins

2006
[Postoperative penicillin-resistant streptococcus pneumonia in lung cancer patient].
    Kyobu geka. The Japanese journal of thoracic surgery, 2008, Volume: 61, Issue:3

    Topics: Aged; Carcinoma, Squamous Cell; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Fatal Outcome; Humans; Imipenem; Klebsiella Infections; Lung Neoplasms; Male; Penicillin Resistance; Pneumonia, Pneumococcal; Postoperative Complications; Sepsis; Streptococcus pneumoniae; Ventilators, Mechanical

2008
Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Diagnostic microbiology and infectious disease, 2008, Volume: 61, Issue:3

    Topics: Anti-Bacterial Agents; beta-Lactamases; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Minocycline; Plasmids; Porins; Tigecycline

2008
Antagonism by chloramphenicol of broad-spectrum beta-lactam antibiotics against Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:4

    Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chloramphenicol; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Thienamycins; Time Factors

1984
Emergence of resistance to imipenem in Enterobacter isolates masquerading as Klebsiella pneumoniae during therapy with imipenem/cilastatin.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:1

    Topics: Aged; Cefoxitin; Cilastatin; Diagnosis, Differential; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male

1993
Safety of imipenem in neonates.
    The Pediatric infectious disease journal, 1995, Volume: 14, Issue:9

    Topics: Dose-Response Relationship, Drug; Humans; Imipenem; Incidence; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Intensive Care Units, Neonatal; Klebsiella Infections; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Thienamycins; Treatment Outcome

1995
[In vitro and in vivo activities of sulopenem compared with those of imipenem and cephalosporins].
    The Japanese journal of antibiotics, 1996, Volume: 49, Issue:4

    Topics: Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; beta-Lactam Resistance; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli Infections; Gram-Negative Bacteria; Gram-Positive Bacteria; Guinea Pigs; Imipenem; Klebsiella Infections; Lactams; Lung Diseases; Mice; Mice, Inbred ICR; Thienamycins

1996
Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:3

    Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; beta-Lactam Resistance; beta-Lactamases; Blotting, Southern; Carbapenems; Disease Outbreaks; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Imipenem; Infant; Isoelectric Focusing; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids

1997
Prolonged continuous i.v. "desensitization" in Tienam hypersensitivity.
    Allergy, 1997, Volume: 52, Issue:6

    Topics: Cilastatin; Cilastatin, Imipenem Drug Combination; Desensitization, Immunologic; Drug Combinations; Drug Hypersensitivity; Drug Therapy, Combination; Female; Humans; Imipenem; Infusions, Intravenous; Klebsiella Infections; Middle Aged

1997
Emergence of a carbapenem-resistant Klebsiella pneumoniae.
    Lancet (London, England), 1997, Sep-13, Volume: 350, Issue:9080

    Topics: beta-Lactam Resistance; Disease Outbreaks; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Scotland; Thienamycins

1997
Piperacillin/tazobactam in the treatment of Klebsiella pneumoniae infections in neonates.
    American journal of perinatology, 1998, Volume: 15, Issue:1

    Topics: Anti-Infective Agents; beta-Lactamase Inhibitors; Cilastatin; Ciprofloxacin; Cross Infection; Drug Combinations; Drug Resistance, Microbial; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Imipenem; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Protease Inhibitors; Retrospective Studies; Tazobactam; Thienamycins

1998
[Comparative activity of cefepime, ceftazidime and imipenem in a mouse infection caused by Klebsiella pneumoniae producing a broad spectrum beta-lactamase].
    Pathologie-biologie, 1998, Volume: 46, Issue:8

    Topics: Animals; beta-Lactamases; Cefepime; Ceftazidime; Cephalosporins; Colony Count, Microbial; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Spleen; Thienamycins

1998
In-vitro selection of porin-deficient mutants of two strains of Klebsiella pneumoniae with reduced susceptibilities to meropenem, but not to imipenem.
    The Journal of antimicrobial chemotherapy, 1998, Volume: 42, Issue:6

    Topics: beta-Lactamases; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Porins; Thienamycins

1998
Clinical characteristics and molecular epidemiology associated with imipenem-resistant Klebsiella pneumoniae.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Thienamycins

1999
In vitro and in vivo activities of amikacin, cefepime, amikacin plus cefepime, and imipenem against an SHV-5 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae strain.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:4

    Topics: Amikacin; Animals; beta-Lactam Resistance; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Imipenem; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Survival Analysis

2001
The in vitro effect of imipenem and ofloxacin on enzymic activity of Klebsiella strains.
    Folia microbiologica, 2000, Volume: 45, Issue:5

    Topics: Anti-Infective Agents; Humans; Imipenem; Klebsiella; Klebsiella Infections; Lipase; Microbial Sensitivity Tests; Ofloxacin; Thienamycins; Urease

2000
[Medical treatment of infected pancreatic necrosis].
    Gastroenterologia y hepatologia, 2001, Volume: 24, Issue:5

    Topics: Aged; Ciprofloxacin; Combined Modality Therapy; Drug Therapy, Combination; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Male; Pancreatitis, Acute Necrotizing; Parenteral Nutrition, Total; Trimethoprim, Sulfamethoxazole Drug Combination

2001
Umbilical catheter-related resistant Klebsiella septicaemia in a pre-term infant successfully treated with imipenem via the catheter.
    The Journal of infection, 1992, Volume: 25, Issue:2

    Topics: Bacteremia; Catheterization; Drug Resistance, Microbial; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Klebsiella Infections; Male; Umbilicus

1992
Pharmacokinetic evidence of imipenem efficacy in the treatment of Klebsiella pneumoniae nosocomial meningitis.
    The Journal of antimicrobial chemotherapy, 1991, Volume: 28, Issue:2

    Topics: Aged; Cross Infection; Humans; Imipenem; Klebsiella Infections; Male; Meningitis, Bacterial

1991
[Evaluation of imipenem/cilastatin sodium in the treatment of respiratory tract infections].
    The Japanese journal of antibiotics, 1990, Volume: 43, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Imipenem; Klebsiella Infections; Male; Middle Aged; Pseudomonas; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus

1990
Comparative antibiotic dose-effect relations at several dosing intervals in murine pneumonitis and thigh-infection models.
    The Journal of infectious diseases, 1989, Volume: 159, Issue:2

    Topics: Animals; Anti-Bacterial Agents; Cefazolin; Ceftazidime; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gentamicins; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lung; Mice; Mice, Inbred ICR; Muscles; Pneumonia

1989
Bactericidal effect of ceftriaxone versus imipenem plus cilastatin in bronchial secretion.
    Chemotherapy, 1988, Volume: 34 Suppl 1

    Topics: Aged; Bronchial Diseases; Ceftriaxone; Cilastatin; Drug Administration Schedule; Drug Combinations; Haemophilus Infections; Haemophilus influenzae; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Middle Aged; Sputum; Streptococcal Infections; Streptococcus pneumoniae

1988
Correlation of antibiotic synergy in vitro and in vivo: use of an animal model of neutropenic gram-negative sepsis.
    The Journal of infectious diseases, 1986, Volume: 154, Issue:4

    Topics: Agranulocytosis; Amikacin; Animals; Drug Synergism; Drug Therapy, Combination; Enterobacteriaceae Infections; Imipenem; Kanamycin; Kinetics; Klebsiella Infections; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections; Rats; Sepsis; Serratia marcescens; Thienamycins

1986